Towards Healthcare
CRISPR Market Size Hits USD 3.27 Billion in 2025

CRISPR Market Insights Services Segment Rising Fast as Ex Vivo Dominates

According to market projections, the CRISPR sector is expected to grow from USD 2.94 billion in 2024 to USD 8.58 billion by 2034, reflecting a CAGR of 11.24%. The market is growing due to rising demand for gene-editing therapies in genetic disorders and cancer treatment. Advancements in biotechnology and increased R&D investments are further accelerating its adoption across healthcare and agriculture.

Content

  • Insight Code: 5966
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

Talk to us
FAQ's

The CRISPR market is projected to reach USD 8.58 billion by 2034, growing at a CAGR of 11.24% from 2024 to 2034.

North America is currently leading the CRISPR market due to its strong biotechnology infrastructure, significant government and private funding, and presence of key market players.

he CRISPR market includes 6 segments by product type, by application, by end user, by therapeutic application, by delivery method, and by region.

Some key players include Synthego Corporation, Horizon Discovery, ToolGen, Inc., Inscripta, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc.

Key trends include the growth due to rising demand for gene-editing therapies in genetic disorders and cancer treatment.

CRISPR is being tested for treating genetic diseases like sickle cell anemia, beta-thalassemia, certain cancers, and rare metabolic disorders.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Any Questions